Jaguar Health, Inc. (JAGX) stock
JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.39−0.03 (-7.14%)
Close on Nov 16, 2026Market cap $2.02MP/E –Yield –
Earnings
Jaguar Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q1 FY2026
$20.27M
EPS, Q1 FY2026
-$13.60
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Jaguar Health's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | Aug 19, 2026after the close | – | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 20, 2026after the close | $20.27M | – | -$13.60 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 15, 2025after the close | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 31, 2025before the open | $3.50M | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 13, 2024before the open | $3.10M | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 13, 2024before the open | $2.72M | +1.6% | -$4.04 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023before the open | $2.68M | – | -$0.42 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 15, 2023before the open | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 27, 2023before the open | $3.30M | +57.1% | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 14, 2022before the open | $3.15M | +400.0% | -$0.12 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 10, 2022before the open | $2.63M | – | -$0.40 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 11, 2022after the close | $2.10M | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 18, 2021after the close | $630.00K | – | -$0.27 | Release |
| Q1 FY2021ended Mar 31, 2021 | May 17, 2021before the open | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 31, 2021after the close | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 16, 2020before the open | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 13, 2020before the open | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | Apr 6, 2020before the open | – | – | – | Filing |
| Q3 FY2019ended Sep 30, 2019 | Nov 15, 2019after the close | – | – | – | Filing |
| Q2 FY2019ended Jun 30, 2019 | Aug 14, 2019after the close | – | – | – | Filing |
| Q1 FY2019ended Mar 31, 2019 | Apr 11, 2019after the close | – | – | – | Filing |
| Q4 FY2018ended Dec 31, 2018 | Jan 8, 2019after the close | – | – | – | Filing |
| Q3 FY2018ended Sep 30, 2018 | Nov 15, 2018after the close | – | – | – | Filing |
| Q2 FY2018ended Jun 30, 2018 | Jul 12, 2018before the open | – | – | – | Filing |
| Q4 FY2017ended Dec 31, 2017 | Jan 22, 2018after the close | – | – | – | Filing |
| Q3 FY2017ended Sep 30, 2017 | Nov 14, 2017after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Jaguar Health has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Jaguar Health puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Jaguar Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Update
- Update
- Results
- News
- Update
- Update
- Update
- Update
- Results
- Update
- Update
- Results
See a number that looks wrong?